MWMia Sohn White

Mia Sohn White

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mia Sohn White has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Ultrasound‐Guided A1 Pulley Release: A Systematic Review

    by Hirotaka Nakagawa, Travis Redmond, Ricardo Colberg, Erek Latzka, Mia S. White, Robert L. Bowers, Walter I. Sussman

    The purpose of this review was to summarize the current literature pertaining to ultrasound‐guided percutaneous A1 pulley release procedures. We searched PubMed, Cochrane Library, Embase, and Web of Science for clinical studies examining ultrasound‐guided percutaneous A1 pulley release. A total of 17 studies involving 749 procedures were included in this review. The overall success rate was 97%. There were 23 minor complications (4 cases of hematomas, 15 cases of persistent pain, and 4 cases of transient numbness) and no major complications reported. Ultrasound‐guided A1 pulley release is an effective and safe procedure for the treatment of trigger fingers and thumb.


  • Male Perpetrators' Accounts of Intimate Femicide

    by Dabney P. Evans, Martín Hernán Di Marco, Subasri Narasimhan, Melanie E. Maino Vieytes, Autumn Curran, Mia S. White

    To prevent intimate femicide an understanding of the perpetrators is necessary. The purpose of this systematic review was to synthesise the evidence on intimate femicide with a focus on the perspectives of male perpetrators. We searched ten databases using terms about femicide and perpetrators (e.g., “husband”). The review had no limits on publication date, geography, study design, or discipline and included articles in English, Spanish, and Portuguese. The search resulted in 4,273 articles; after exclusion criteria were applied, the full text of 112 articles was reviewed. Data were extracted from 14 studies. All studies sampled incarcerated populations. Articles used varied terminology and were grounded in gender and power, psychology, or social development theory. Most used qualitative approaches (n = 11), primarily semi-structured interviews (n = 8). Common themes across studies included perpetrator biographical and predisposing factors, self-narratives, and sense-making. Perpetrators rationalised the femicide and deflected responsibility, viewed themselves as the victim while vilifying true victims, and adhered to strict gender norms. Femicide accounts and stories shared strikingly similar narrative patterns relative to violence and conceptions of gender roles. This review underscores the importance of and absences in work focusing on intimate femicide perpetrator’s perspectives across methodologies and disciplines – namely, criminology and masculinity studies. Intimate femicide perpetrators are not merely individual offenders, instead they are a manifestation of a global patriarchy who pose mortal threats to their female partners. As drivers of intimate femicide, information about perpetrator motivations and rationalisations is necessary for effective policy and programmatic interventions to save women’s lives.


  • Open Access

    Demographic Gaps and Requirements for Participation: A Systematic Review of Clinical Trial Designs in Hidradenitis Suppurativa

    by JaBreia Fanita James, Victoria M. Madray, Nicole Salame, Samar Babikir Hasan, Mia Sohn White, Jason Richard Barron, Joslyn Kirby, John Robert Ingram, Lauren Anne Vigil Orenstein

    Background: Hidradenitis suppurativa (HS) is a chronic inflammatory disease that disproportionally affects women, as well as Black and biracial individuals. While adalimumab remains the only therapy approved by the Food and Drug Administration for HS, many HS clinical trials for novel and re-tasked therapies are ongoing or upcoming. To optimize treatment equity, reflect the patient population, and facilitate trial participation, it is important to elucidate aspects of clinical trial protocols that may systematically exclude specific patient groups or impose hardships. Objective: The study aimed to systematically review inclusion and exclusion criteria as well as participant demographics in HS clinical trials. Methods: A literature search of PubMed, Embase, Cochrane Central, and Web of Science databases was conducted. Peer-reviewed publications of randomized controlled trials that were written in English and had at least 10 participants were included. Title and abstract screening and data extraction were completed by two independent reviewers, with disagreements resolved by a third. Results: Twenty-three studies totaling 1,496 adult participants met the inclusion criteria. Race and ethnicity were not reported in 473/1,496 (31.6%) and 1,420/1,496 (94.9%) trial participants, respectively. Trial participants were predominantly white (811/1,023, 79.3%) and female (1,057/1,457, 72.5%). The median of each study’s average age was 35.7 years (IQR 33.5–38.0), and 17/23 (73.9%) trials excluded pediatric patients. Nearly all participants had Hurley Stage II (499/958, 52.0%) or Hurley Stage III (385/958, 40.2%) disease. Many trials excluded patients who were pregnant (19/23, 82.6%) and breastfeeding (13/23, 56.5%), or who had HS that was “too severe” (8/23, 34.8%) or “too mild” (16/23, 70.0%). Frequently, trial protocols required prolonged washout periods from HS therapies, relatively long duration in the study’s placebo arm, and prohibited concurrent analgesic use. Conclusions: This systematic review of 23 HS clinical trials totaling 1,496 participants identified substantial hardships imposed by trial participation, high rates of missing race and ethnicity data, and low representation of key patient groups, including those who identify as Black. Future trials with pragmatic study designs, broader inclusion criteria, and study sites in diverse communities may alleviate burdens of trial participation and improve enrollment of diverse patient groups.


  • Bullying and Children who are Deaf or Hard‐of‐hearing: A Scoping Review

    by Emerson Bouldin Ba, Shubham R. Patel, Ching Siong Tey, Mia White, Kristan P. Alfonso, Nandini Govil

    Objective/Hypothesis: The goal of this scoping review is to evaluate and synthesize the published research regarding bullying and children who are deaf or hard‐of‐hearing (DHH).Study Design: The Preferred Reporting Items for Systematic Reviews and Meta‐Analyses extension for scoping review (PRISMA‐ScR) statement was used as the guideline for conducting this review.Methods: This review included studies assessing pediatric (0–21 years) DHH children. Seventy records underwent the initial title‐abstract screening, 33 underwent full‐text review, and 23 studies met inclusion criteria. During the data extraction process, an additional six were excluded, resulting in a total of 17 evaluated studies.Results: Of the 17 studies assessed, nine compared peer victimization of DHH children and their hearing peers. Of those, seven studies reported that hearing loss (HL) is significantly associated with increased victimization. Two studies found that HL is significantly associated with decreased bullying perpetration. Notably, bullying in DHH children was not associated with a visible sign of disability, such as a hearing assistive device. Rather, variables such as educational setting, parental, and peer support are more likely to mediate bullying in this population.Conclusions: DHH children have a higher risk of peer victimization and may bully others less often than their hearing peers. Studies described the health consequences of bullying in children who are DHH, including sleep issues and anxiety. These consequences may have implications for the patients' overall HL management. Additional research regarding bullying interventions and prevention in this population should be conducted.Level of Evidence: NA Laryngoscope, 131:1884–1892, 2021